Close Menu

University of Utah

John Opitz, a medical geneticist at the University of Utah, has been awarded the William Allan Award by the American Society of Human Genetics for his work in identifying and understanding genetic syndromes.

By Justin Petrone
Salt Lake City Bioscience plans to commercialize a new technology platform developed by the University of Utah.

Researchers using exome sequencing to study ADHD found rare mutations they think may be causing a patient's anemia, raising the question of how to handle unrelated findings in sequencing studies.

According to the amended complaint, University of Utah's Brenda Bass had “so well-defined” the concept at issue that it "could have been reduced to practice by someone with ordinary skill in the art without further research.”

Allegro CEO Mike Webb said the licensing agreement will support the "continued advancement" of the firm's BronchoGen test, including a planned commercial launch in the first half of 2012.

Omicia, which co-developed VAAST with Mark Yandell’s group at the University of Utah, is now working on integrating the algorithm into a platform called the Genome Analysis System, which it plans to release commercially at the end of the third quarter.

The IP licensed by Allegro relates to a gene expression-based platform that detects common molecular responses that occur throughout the respiratory tract in current and former smokers with lung cancer.

Brenda Bass “conceived the inventions of all the issued claims of Tuschl-II and at least some pending claims of Tuschl-I well before any date asserted by the currently named inventors,” the University of Utah alleges.

The company is using a quantitative PCR method licensed from the University of Utah to measure telomere length from tissue samples for research, drug-development, and health-monitoring applications.

In the lawsuit, which comes just days after Alnylam said it settled a different suit related to the IP, the University of Utah alleges that one of its researchers actually invented the technology covered by the Tuschl-II patent estate.

Pages

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.